Glassman Wealth Services Neurocrine Biosciences Inc Transaction History

Glassman Wealth Services

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$89.53 - $104.87 $537 - $629	6 Added 4.11%	152 $14,000
Q1 2023 May 04, 2023	SELL	$94.11 - $123.02 $376 - $492	-4 Reduced 2.67%	146 $14,000
Q4 2022 Feb 06, 2023	BUY	$106.72 - $127.06 $426 - $508	4 Added 2.74%	150 $17,000
Q2 2022 Aug 04, 2022	BUY	$75.79 - $100.07 $10,534 - $13,909	139 Added 1985.71%	146 $14,000
Q1 2022 Apr 14, 2022	SELL	$72.45 - $94.81 $8,621 - $11,282	-119 Reduced 94.44%	7 $1,000
Q4 2021 Feb 14, 2022	SELL	$79.65 - $106.22 $3,424 - $4,567	-43 Reduced 25.44%	126 $11,000
Q3 2021 Nov 10, 2021	BUY	$86.18 - $99.03 $2,068 - $2,376	24 Added 16.55%	169 $16,000
Q1 2021 May 05, 2021	BUY	$87.57 - $119.4 $1,576 - $2,149	18 Added 14.17%	145 $14,000
Q4 2020 Feb 04, 2021	BUY	$86.91 - $108.33 $6,605 - $8,233	76 Added 149.02%	127 $12,000
Q3 2020 Nov 09, 2020	BUY	$96.16 - $135.15 $961 - $1,351	10 Added 24.39%	51 $5,000
Q2 2020 Aug 06, 2020	BUY	$85.09 - $130.36 $2,722 - $4,171	32 Added 355.56%	41 $5,000
Q1 2020 May 12, 2020	BUY	$75.11 - $113.76 $375 - $568	5 Added 125.0%	9 $1,000
Q4 2019 Feb 07, 2020	SELL	$86.8 - $118.57 $260 - $355	-3 Reduced 42.86%	4 $0
Q3 2019 Nov 01, 2019	BUY	$83.82 - $101.5 $251 - $304	3 Added 75.0%	7 $1,000
Q2 2019 Aug 08, 2019	BUY	$72.24 - $91.27 $288 - $365	4 New	4 $0

656

96.6M

282K

281K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $10.7B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.